Stifel Raises Price Target on Veeva Systems (VEEV) to $43 Following 2Q Beat and Raise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Pre-Open Stock Movers 08/31: (CHS) (ININ) (VEEV) Higher; (AVAV) (PANW) (HRB) Lower (more...)
August 31, 2016 9:30 AM EDTToday's After-Hours Movers
AeroVironment (NASDAQ: AVAV) 12.8% LOWER; reported Q1 EPS of ($0.51), may not compare to the analyst estimate of ($0.17). Revenue for the quarter came in at $36.2 million versus the consensus estimate of $37.81 million.
Needham & Company Raises Price Target on Veeva Systems (VEEV) Following 2Q report
August 31, 2016 7:27 AM EDTNeedham & Company reiterated a Buy rating Veeva Systems (NYSE: VEEV) price target of $43.00 (from $38.00), following the company's 2Q earnings report. VEEV reported Revenues and EPS of $131.3mm and $0.15, ahead of $126.3mm/$0.13 estimates.
Analyst Scott Berg commented, "Veeva reported another impressive quarter with revenue... More
After-Hours Stock Movers 08/30: (VEEV) (GSAT) (NCS) Higher; (AVAV) (MDCO) (HRB) (PANW) Lower (more...)
August 30, 2016 5:44 PM EDTToday's After-Hours Movers
AeroVironment (NASDAQ: AVAV) 13.3% LOWER; reported Q1 EPS of ($0.51), may not compare to the analyst estimate of ($0.17). Revenue for the quarter came in at $36.2 million versus the consensus estimate of $37.81 million.
The Medicines Company (Nasdaq: MDCO) 8% LOWER; provided an update on its clinical dyslipidemia research programs for MDCO-216 (which contains APoA-1 Milano) and PCSK9si (PCSK9 synthesis inhibitor). MDCO-216. A planned, interim analysis of the first 40 randomized patients completing treatment in the MILANO-PILOT... More
Veeva Systems (VEEV) Tops Q2 EPS by 2c; Issues Street Guidance
August 30, 2016 4:06 PM EDTVeeva Systems (NYSE: VEEV) reported Q2 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $131.3 million versus the consensus estimate of $126.57 million.
GUIDANCE:
Veeva Systems sees Q3 2017 EPS of $0.15-$0.16, versus the consensus of... More
Trading Radar for 8/30: Abercrombie & Fitch (ANF), Palo Alto Networks (PANW), Veeva Systems (VEEV) Report
August 29, 2016 2:58 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
9:00am EDT
Earnings:
